- Home
- CDIO vs IBG Comparison
CDIO vs IBG Comparison
Compare CDIO & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- IBG
- Stock Information
- Founded
- CDIO 2017
- IBG 2018
- Country
- CDIO United States
- IBG Australia
- Employees
- CDIO N/A
- IBG N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- IBG Beverages (Production/Distribution)
- Sector
- CDIO Health Care
- IBG Consumer Staples
- Exchange
- CDIO Nasdaq
- IBG Nasdaq
- Market Cap
- CDIO 6.4M
- IBG 5.4M
- IPO Year
- CDIO N/A
- IBG 2024
- Fundamental
- Price
- CDIO $3.63
- IBG $0.64
- Analyst Decision
- CDIO Buy
- IBG Strong Buy
- Analyst Count
- CDIO 1
- IBG 1
- Target Price
- CDIO $60.00
- IBG N/A
- AVG Volume (30 Days)
- CDIO 41.9K
- IBG 680.2K
- Earning Date
- CDIO 08-14-2025
- IBG 08-26-2025
- Dividend Yield
- CDIO N/A
- IBG N/A
- EPS Growth
- CDIO N/A
- IBG N/A
- EPS
- CDIO N/A
- IBG N/A
- Revenue
- CDIO $19,507.00
- IBG $2,931,243.00
- Revenue This Year
- CDIO $1,434.82
- IBG N/A
- Revenue Next Year
- CDIO $4,661.91
- IBG N/A
- P/E Ratio
- CDIO N/A
- IBG N/A
- Revenue Growth
- CDIO N/A
- IBG N/A
- 52 Week Low
- CDIO $3.22
- IBG $0.44
- 52 Week High
- CDIO $53.10
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- CDIO 41.96
- IBG N/A
- Support Level
- CDIO $3.58
- IBG N/A
- Resistance Level
- CDIO $4.05
- IBG N/A
- Average True Range (ATR)
- CDIO 0.33
- IBG 0.00
- MACD
- CDIO -0.01
- IBG 0.00
- Stochastic Oscillator
- CDIO 24.74
- IBG 0.00
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.